|
|
||||||||
1 Department of Pharmacology, Physiology, and Therapeutics, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota 58203; and 2 Department of Pediatrics, University of Louisville School of Medicine, Louisville, Kentucky 40202
This study characterized the cardiac
contractile function and IGF-I response in a transgenic diabetic mouse
model. Mechanical properties were evaluated in cardiac myocytes from
OVE26 diabetic and FVB wild-type mice, including peak shortening (PS),
time to PS (TPS), time to 90% relengthening (TR90) and
maximal velocity of shortening/relengthening
(±dL/dt). Intracellular Ca2+ was
evaluated as Ca2+-induced Ca2+ release
[difference in fura 2 fluorescent intensity (
FFI)] and fluorescence decay rate (
). Sarco(endo)plasmic reticulum
Ca2+-ATPase (SERCA)2a, phospholamban (PLB),
Na+-Ca2+ exchanger (NCX), GLUT4, and the
serine-threonine kinase Akt were assessed by Western blot. RhoA and
IGF-I/IGF-I receptor mRNA levels were determined by RT-PCR and Northern
blot. OVE26 myocytes displayed decreased PS,
±dL/dt, and
FFI associated with prolonged
TPS, TR90, and
. SERCA2a, NCX, and Akt activation were
reduced, whereas PLB and RhoA were enhanced in OVE26 hearts. GLUT4 was
unchanged. IGF-I enhanced PS and
FFI in FVB but not OVE26 myocytes.
IGF-I mRNA was increased, but IGF-I receptor mRNA was reduced in OVE26 hearts and livers. These results validate diabetic cardiomyopathy in
OVE26 mice due to reduced SERCA2, NCX, IGF-I response, and Akt
activation associated with enhanced RhoA level, suggesting a
therapeutic potential for Akt and RhoA.
diabetic mouse; ventricular myocyte; excitation-contraction coupling; insulin-like growth factor I; sarco(endo)plasmic reticulum Ca2+-ATPase; sodium-calcium exchanger
This article has been cited by other articles:
![]() |
J. Ren, J. Duan, D. P. Thomas, X. Yang, N. Sreejayan, J. R. Sowers, A. Leri, J. Kajstura, F. Gao, and P. Anversa IGF-I alleviates diabetes-induced RhoA activation, eNOS uncoupling, and myocardial dysfunction Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R793 - R802. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Dong, M. M. Taylor, W. K. Samson, and J. Ren Intermedin (adrenomedullin-2) enhances cardiac contractile function via a protein kinase C- and protein kinase A-dependent pathway in murine ventricular myocytes J Appl Physiol, September 1, 2006; 101(3): 778 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Ceylan-Isik, K. H. LaCour, and J. Ren Sex difference in cardiomyocyte function in normal and metallothionein transgenic mice: the effect of diabetes mellitus J Appl Physiol, May 1, 2006; 100(5): 1638 - 1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yang, T. A. Doser, C. X. Fang, J. M. Nunn, R. Janardhanan, M. Zhu, N. Sreejayan, M. T. Quinn, and J. Ren Metallothionein prolongs survival and antagonizes senescence-associated cardiomyocyte diastolic dysfunction: role of oxidative stress FASEB J, May 1, 2006; 20(7): 1024 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Dong, X Zhang, X Yang, L B Esberg, H Yang, Z Zhang, B Culver, and J Ren Impaired cardiac contractile function in ventricular myocytes from leptin-deficient ob/ob obese mice J. Endocrinol., January 1, 2006; 188(1): 25 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Ceylan-Isik, S. Wu, Q. Li, S.-Y. Li, and J. Ren High-dose benfotiamine rescues cardiomyocyte contractile dysfunction in streptozotocin-induced diabetes mellitus J Appl Physiol, January 1, 2006; 100(1): 150 - 156. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |